David Eansor

Overview

David Eansor received an average of $2M in total compensation, including $462K in salary, at Bio-Techne from 2017 to 2019.

Source: SEC filing on September 9, 2019.

Related executives

We found seven more executives who work or worked at Bio-Techne.

Charles Kummeth

Bio-Techne

Chief Executive Officer

James Hippel

Bio-Techne

Chief Financial Officer

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

Brenda Furlow

Bio-Techne

General Counsel

Marcel Veronneau

Bio-Techne

Vice President Hematology Operations

Gregory Melsen

Bio-Techne

Chief Financial Officer

Thomas Oland

Bio-Techne

Chief Executive Officer

News

You may also like